Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia
Key facts
- Who runs it
- Zeng Changhao
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 30 Jan 2024
- Ended
- 15 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Conventional Care
- Intermittent Oral-esophageal Tube Feeding
- Nasogastric tube
- Record updated
- 5 March 2024
- Why it stopped
- ethical issues
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- age between 18 years and 85 years, meeting the diagnosis of Alzheimer's Disease
- presence of no contraindication for enteral nutrition
- with dysphagia verified by Imaging materials
- with stable vital signs and no severe liver or kidney dysfunction, metabolic disorders, cardiovascular diseases, or multiple complications
- Minimum Mental State Examination ranging from 10-26
Who cannot take part
- unable to cooperate in completing treatment and assessment due to personal reasons or other disorders
- complicated with other intracranial lesions, such as stroke
- abnormal structure of swallowing-related organ and tissue
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective multicenter study with Alzheimer's patients with dysphagia. Patients enrolled are randomly divided equally into the observation group and the control group. All patients receive conventional care, and the observation group received Intermittent Oral-esophageal Tube Feeding while the control group received Nasogastric Tube Feeding for enteral nutrition support. Baseline information (demographics, medical history, etc.), nutritional status at admission and after treatment, depression, dysphagia, and quality of life after treatment are compared.
The 2 groups in the trial
- The observation groupTreatment being tested
During the 15-day treatment, both groups of patients are hospitalized, while conventional care and enteral nutrition support are provided to the two groups. The observation group receives Intermittent Oral-esophageal Tube Feeding for enteral nutrition support
Treatment: Conventional Care and Intermittent Oral-esophageal Tube Feeding
- The control groupExisting treatment, for comparison
During the 15-day treatment, both groups of patients are hospitalized, while conventional care and enteral nutrition support are provided to the two groups. The control group receives Nasogastric Tube Feeding for enteral nutrition support
Treatment: Conventional Care and Nasogastric tube
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Observation of Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia: A Randomly Controlled Study
- Record updated
- 5 March 2024